RE:RE:RE:RE:Response from Frederic40 wrote: Bsmart, I have talk to Fred last week about the the program between FDA and DoD and I had the same answer as Stockman.
This is not a forgery or a lie.
Fred would not say that Prometic is already in contact with the DoD about the use of Ryplazim if it was not true.
I am surprized that there is not more reaction about this on the bullboard.
In my opinion, this is very interesting as the department of defense (the US army) as no interest in Ryplazim for congenital deficiancy. IMHO, they must have an interest in wound and burned healing.
If they can heal a soldier or any member of the army faster, it is a strategic tool for them.
A wounded soldier takes much more ressources than a dead soldier. It is a known fact in the army. During a conflict, you better wound the enemy then kill them because of that.
So if the army have a drug that help the healing of their troops, it it a strategic tool.
Anyway, time will tell.
Thus the creation of fully jacketed ammo - go thru you making a small hole and not killing you. Resulted in two guys having to go pick you up meaning three were out of combat... But I digress. Talking to or even with the US DoD and getting a deal done with them are two completely different things. Yes it makes sense, but until it happens I give it an extremely low probability.